• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.迷幻药医学化中的知识空白:临床前和神经影像学机制
Neurosci Appl. 2023 Dec 15;3:103929. doi: 10.1016/j.nsa.2023.103929. eCollection 2024.
2
Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.致幻剂辅助治疗对患有危及生命疾病的人群的焦虑、抑郁和存在性困扰的治疗作用。
Cochrane Database Syst Rev. 2024 Sep 12;9(9):CD015383. doi: 10.1002/14651858.CD015383.pub2.
3
The Black Book of Psychotropic Dosing and Monitoring.《精神药物剂量与监测黑皮书》
Psychopharmacol Bull. 2024 Jul 8;54(3):8-59.
4
Knowledge gaps in psychedelic medicalisation: Clinical studies and regulatory aspects.迷幻药医学化中的知识空白:临床研究与监管方面。
Neurosci Appl. 2024 Jan 11;3:103938. doi: 10.1016/j.nsa.2024.103938. eCollection 2024.
5
From molecules to meaning: unpacking the antidepressant mechanisms of psychedelic drugs.从分子到意义:解析迷幻药物的抗抑郁机制
Expert Rev Clin Pharmacol. 2025 May;18(5):263-280. doi: 10.1080/17512433.2025.2515866. Epub 2025 Jun 11.
6
CCNP Innovations in Neuropsychopharmacology Award: The psychopharmacology of psychedelics: where the brain meets spirituality.CCNP 神经精神药理学创新奖:迷幻剂的精神药理学:大脑与精神的交汇点。
J Psychiatry Neurosci. 2024 Sep 19;49(5):E301-E318. doi: 10.1503/jpn.240037. Print 2024 Sep-Oct.
7
Role of endogenous serotonin in psychedelic-like effects of psilocybin in mice.内源性血清素在裸盖菇素对小鼠致幻样效应中的作用。
Int J Neuropsychopharmacol. 2025 Jun 6;28(6). doi: 10.1093/ijnp/pyaf035.
8
History of psychedelic drug science and molecular pharmacology.迷幻药科学与分子药理学的历史。
Int Rev Neurobiol. 2025;181:3-43. doi: 10.1016/bs.irn.2025.02.001. Epub 2025 Feb 27.
9
Neurocognitive effects of psilocybin: A systematic and comprehensive review of neuroimaging studies in humans.裸盖菇素的神经认知效应:对人类神经影像学研究的系统全面综述。
Neurosci Biobehav Rev. 2025 Aug;175:106239. doi: 10.1016/j.neubiorev.2025.106239. Epub 2025 May 31.
10
Human neuroimaging: fMRI.人类神经影像学:功能磁共振成像
Int Rev Neurobiol. 2025;181:149-170. doi: 10.1016/bs.irn.2025.04.013. Epub 2025 Jun 6.

本文引用的文献

1
Sex Differences in Stress Response: Classical Mechanisms and Beyond.性别在应激反应中的差异:经典机制及其他。
Curr Neuropharmacol. 2024;22(3):475-494. doi: 10.2174/1570159X22666231005090134.
2
Repeated low doses of psilocybin increase resilience to stress, lower compulsive actions, and strengthen cortical connections to the paraventricular thalamic nucleus in rats.重复给予低剂量裸盖菇素可增强大鼠的抗压能力、降低强迫行为,并增强皮质与室旁丘脑核的连接。
Mol Psychiatry. 2023 Sep;28(9):3829-3841. doi: 10.1038/s41380-023-02280-z. Epub 2023 Oct 2.
3
Psychedelics reopen the social reward learning critical period.迷幻剂重新开启社会奖励学习的关键期。
Nature. 2023 Jun;618(7966):790-798. doi: 10.1038/s41586-023-06204-3. Epub 2023 Jun 14.
4
Psychedelics promote plasticity by directly binding to BDNF receptor TrkB.迷幻剂通过直接与脑源性神经营养因子受体 TrkB 结合来促进可塑性。
Nat Neurosci. 2023 Jun;26(6):1032-1041. doi: 10.1038/s41593-023-01316-5. Epub 2023 Jun 5.
5
5-MeO-DMT modifies innate behaviors and promotes structural neural plasticity in mice.5-MeO-DMT 改变先天行为并促进小鼠的结构神经可塑性。
Neuropsychopharmacology. 2023 Aug;48(9):1257-1266. doi: 10.1038/s41386-023-01572-w. Epub 2023 Apr 4.
6
Human brain effects of DMT assessed via EEG-fMRI.通过 EEG-fMRI 评估 DMT 对人脑的影响。
Proc Natl Acad Sci U S A. 2023 Mar 28;120(13):e2218949120. doi: 10.1073/pnas.2218949120. Epub 2023 Mar 20.
7
Preclinical perspectives on the mechanisms underlying the therapeutic actions of psilocybin in psychiatric disorders.精神障碍中致幻蘑菇治疗作用的潜在机制的临床前研究。
Neuropharmacology. 2023 Jun 15;231:109504. doi: 10.1016/j.neuropharm.2023.109504. Epub 2023 Mar 13.
8
Increasing resolution in stress neurobiology: from single cells to complex group behaviors.提高应激神经生物学的分辨率:从单细胞到复杂的群体行为。
Stress. 2023 Jan;26(1):2186141. doi: 10.1080/10253890.2023.2186141.
9
Psychedelics promote neuroplasticity through the activation of intracellular 5-HT2A receptors.迷幻剂通过激活细胞内 5-HT2A 受体来促进神经可塑性。
Science. 2023 Feb 17;379(6633):700-706. doi: 10.1126/science.adf0435. Epub 2023 Feb 16.
10
Toward Mapping Neurobehavioral Heterogeneity of Psychedelic Neurobiology in Humans.迈向人类迷幻神经生物学神经行为异质性的映射。
Biol Psychiatry. 2023 Jun 15;93(12):1061-1070. doi: 10.1016/j.biopsych.2022.10.021. Epub 2022 Dec 7.

迷幻药医学化中的知识空白:临床前和神经影像学机制

Knowledge gaps in psychedelic medicalisation: Preclinical and neuroimaging mechanisms.

作者信息

McCulloch Drummond E-Wen, Lopez Juan Pablo, Dalla Christina, Castrén Eero, Erritzoe David, Frokjaer Vibe G, Lundberg Johan, Preller Katrin H, Fisher Patrick MacDonald, Knudsen Gitte Moos

机构信息

Neurobiology Research Unit, Rigshospitalet, and University of Copenhagen, Copenhagen, Denmark.

Department of Neuroscience, Karolinska Institute, Solna, 171 77, Sweden.

出版信息

Neurosci Appl. 2023 Dec 15;3:103929. doi: 10.1016/j.nsa.2023.103929. eCollection 2024.

DOI:10.1016/j.nsa.2023.103929
PMID:40656118
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12244124/
Abstract

Classical psychedelic drugs, e.g., psilocybin and LSD, stimulate the serotonin 2A receptor (5-HT2AR) and have recently been intensely investigated for their clinical effects in various brain disorders. At the ECNP "New Frontiers meeting" in March 2023, scientific experts in psychedelics met to identify key knowledge gaps in the mechanism of action of psychedelics as investigated using preclinical models and clinical neuroimaging. Key themes included the development of appropriate behavioural models for measuring acute and persisting effects, dose optimisation, molecular mechanisms of action, sex differences, and the acute and persisting effects of psychedelics on neurotransmitter release and functional brain activity.

摘要

经典致幻药物,如裸盖菇素和麦角酸二乙酰胺(LSD),可刺激5-羟色胺2A受体(5-HT2AR),最近人们对其在各种脑部疾病中的临床效果进行了深入研究。在2023年3月举行的欧洲神经精神药理学会(ECNP)“新前沿会议”上,致幻剂领域的科学专家齐聚一堂,以确定在使用临床前模型和临床神经影像学研究致幻剂作用机制方面的关键知识空白。关键主题包括开发用于测量急性和持续效应的适当行为模型、剂量优化、分子作用机制、性别差异,以及致幻剂对神经递质释放和大脑功能活动的急性和持续影响。